Ansgar Weltermann

4.8k citations

69 papers · 2.9k indexed · 1 hit paper · h-index 24

Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management 26
Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 24
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 6
- Platelet Disorders and Treatments 6
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes 9
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 5
Emergency Medical Services top 5%
Surgery
- Heparin-Induced Thrombocytopenia and Thrombosis 5

Co-authors: Paul A. Kyrle Sabine Eichinger Erich Minar Mirko Hirschl Christine Bialonczyk Klaus Lechner Barbara Schneider Milena Stain
Cited by: Internal Medicine Hematology Cardiology and Cardiovascular Medicine
Partner nations: Austria Germany United States

In The Last Decade

Ansgar Weltermann

66 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ansgar Weltermann

Since Specialization

Citations

This map shows the geographic impact of Ansgar Weltermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansgar Weltermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansgar Weltermann more than expected).

Fields of papers citing papers by Ansgar Weltermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansgar Weltermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansgar Weltermann. The network helps show where Ansgar Weltermann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ansgar Weltermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ansgar Weltermann Line = papers co-authored together Ansgar Weltermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion Alexander Nikoloudis,Veronika Buxhofer-Ausch,Christoph Aichinger,Michaela Binder,Petra Hasengruber,Emine Kaynak,Dagmar Wipplinger,Robert Milanov,Irene Strassl,Olga Stiefel,Sigrid Machherndl‐Spandl,Andreas Petzer,Ansgar Weltermann,Johannes Clausen	2024	0
2	Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis Alexander Nikoloudis,Ines Julia Neumann,Veronika Buxhofer‐Ausch,Sigrid Machherndl‐Spandl,Michaela Binder,Emine Kaynak,Robert Milanov,Stefanie Nocker,Olga Stiefel,Irene Straßl,Dagmar Wipplinger,Margarete Moyses,Heidrun Kerschner,Petra Apfalter,Michael Girschikofsky,Andreas Petzer,Ansgar Weltermann,Johannes Clausen	2023	2
3	Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience Irene Straßl,Alexander Nikoloudis,Sigrid Machherndl‐Spandl,Veronika Buxhofer‐Ausch,Michaela Binder,Dagmar Wipplinger,Olga Stiefel,Emine Kaynak,Robert Milanov,Christoph Aichinger,Stefanie Nocker,Thomas Bauer,Stefanie Kreissl,Michael Girschikofsky,Andreas Petzer,Ansgar Weltermann,Johannes Clausen	2023	2
4	TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer Irene Straßl,Armin Windhager,Sigrid Machherndl‐Spandl,Veronika Buxhofer‐Ausch,Olga Stiefel,Ansgar Weltermann	2023	0
5	Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience Andreas Springer,J. Hammer,E. Winkler,C. Track,Roswitha Huppert,Alexandra Böhm,H. Kasparu,Ansgar Weltermann,Gregor Aschauer,Andreas L. Petzer,E. Putz,A. Altenburger,R. Gruber,K. Moser,Karin Wiesauer,Hans Geinitz	2016	67
6	A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversity Guerkan Sengoelge,Wolfgang Winnicki,Anne Kupczok,Arndt von Haeseler,Michael Schuster,Walter Pfaller,Paul Jennings,Ansgar Weltermann,Sophia M. Blake,Gere Sunder‐Plassmann	2014	10
7	Niedermolekulare Heparine zur Überbrückung der Pause von Vitamin-K-Antagonisten während interventioneller Eingriffe – Expertenkonsensus Herbert Watzke,Helfried Metzler,Ansgar Weltermann,Peter Marschang,Marianne Brodmann,Wilfried Lang,Ingrid Pabinger-Fasching,Elisabeth Mahla,Sibylle A. Kozek‐Langenecker,M. Guschmann,Kurt Huber	2013	1
8	Management of dabigatran-induced bleeding: expert statement D Friès,Alexander Giurea,M. Gütl,Walter‐Michael Halbmayer,Sibylle A. Kozek‐Langenecker,A. Pachucki,Franz Xaver Roithinger,Barbara Steinlechner,H Thaler,Ansgar Weltermann	2013	12
9	Tissue factor exposing microparticles in inflammatory bowel disease Julia Palkovits,Gottfried Novacek,Marietta Kollars,Gregor Hron,W. Osterode,Peter Quehenberger,Paul A. Kyrle,Harald Vogelsang,Walter Reinisch,Pavol Papay,Ansgar Weltermann	2012	22
10	Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans Barbara Lubsczyk,Marietta Kollars,Gregor Hron,Paul A. Kyrle,Ansgar Weltermann,Verena Gartner	2010	27
11	Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism Stefan Mustafa,Ansgar Weltermann,Robert Fritsche,Claudia Marsik,Oswald Wagner,Paul A. Kyrle,Sabine Eichinger	2008	35
12	Circulating tissue factor-exposing microparticles Daniel Lechner,Ansgar Weltermann	2008	53
13	Chemotherapy-Induced Thrombosis: A Role for Microparticles and Tissue Factor? Daniel Lechner,Ansgar Weltermann	2008	28
14	Autoimmunthrombozytopenie (AITP) des Erwachsenen: Klinik, Diagnose und Therapie Klaus Lechner,Ansgar Weltermann,Ingrid Pabinger	2006	2
15	Family History for Venous Thromboembolism and the Risk for Recurrence Gregor Hron,Sabine Eichinger,Ansgar Weltermann,Erich Minar,Christine Bialonczyk,Mirko Hirschl,Milena Stain,Verena Gartner,Paul A. Kyrle	2006	49
16	High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension Diana Bonderman,Peter L. Turecek,Johannes Jakowitsch,Ansgar Weltermann,Christopher Adlbrecht,Barbara Schneider,Meinhard Kneußl,Lewis J. Rubin,Paul A. Kyrle,Walter Klepetko,Gerald Maurer,Iréne Lang	2003	161
17	Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma H. Kaufmann,Elisabeth Krömer,Thomas Nösslinger,Ansgar Weltermann,Jutta Ackermann,Regina Reisner,M. Bernhart,Johannes Drach	2003	24
18	Superficial thrombophlebitis and risk for recurrent venous thromboembolism Verena Schönauer,Paul A. Kyrle,Ansgar Weltermann,Erich Minar,Christine Bialonczyk,Mirko Hirschl,Peter Quehenberger,Barbara Schneider,H Partsch,Sabine Eichinger	2003	36
19	Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16) Birgit Kainz,Daniel Heintel,Rodrig Marculescu,Ilse Schwarzinger,Wolfgang R. Sperr,Trang Le,Ansgar Weltermann,Christa Fonatsch,Oskar A. Haas,Christine Mannhalter,Klaus Lechner,Ulrich Jaeger	2002	61
20	The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism Sabine Eichinger,Ansgar Weltermann,Christine Mannhalter,Erich Minar,Christine Bialonczyk,Mirko Hirschl,Verena Schönauer,Klaus Lechner,Paul A. Kyrle	2002	59

About Ansgar Weltermann

Ansgar Weltermann is a scholar working on Internal Medicine, Hematology and Genetics, having authored 69 papers that have together received 2.9k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (26 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers), Atrial Fibrillation Management and Outcomes (9 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). The work is most often cited by research in Internal Medicine (1.5k citations), Hematology (1.7k citations) and Cardiology and Cardiovascular Medicine (975 citations). Ansgar Weltermann has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Paul A. Kyrle, Sabine Eichinger, Erich Minar, Mirko Hirschl, Christine Bialonczyk, Klaus Lechner, Barbara Schneider, Milena Stain, Wolfgang Speiser and Peter Quehenberger.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact